Kotak Healthcare Fund Direct - IDCW Reinvestment
NAV
₹13.9770
as on 01 Aug 2025, 11:12 PM
₹-0.3180(2.22%)
Last Change
Scheme Information
Kotak Healthcare Fund Direct - IDCW Reinvestment
as of 30 Jun 2025, 05:30 AM
₹453.45 Cr
0.79%
1.87%
Open-End
Growth
0.5% for redemption within 30 Days
NIFTY Healthcare Total Return Index.
View
Sectors Holding in this Mutual Fund
Healthcare
98.13%
₹444.97 Cr
Cash Holding
1.87%
₹8.48 Cr
Healthcare
98.13%
₹444.97 Cr
Cash Holding
1.87%
₹8.48 Cr
Sun Pharmaceutical Industries Ltd.
15.44%
₹70.01 Cr
Max Healthcare Institute Ltd.
7.90%
₹35.82 Cr
Divi's Laboratories Ltd.
6.09%
₹27.61 Cr
Cipla Ltd.
5.06%
₹22.94 Cr
Others
65.51%
₹297.05 Cr
Sun Pharmaceutical Industries Ltd.
15.44%
₹70.01 Cr
Max Healthcare Institute Ltd.
7.90%
₹35.82 Cr
Divi's Laboratories Ltd.
6.09%
₹27.61 Cr
Cipla Ltd.
5.06%
₹22.94 Cr
Others
65.51%
₹297.05 Cr
Funds in this Category
This fund's returns: 8.30%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
Min. Investment
₹100
22.09
Category Returns
-6.82%
22.09%
3Y Returns
22.09 %
HDFC Pharma And Healthcare Fund Direct - Growth
Min. Investment
₹100
18.87
Category Returns
-6.82%
22.09%
3Y Returns
18.87 %
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth
Min. Investment
₹100
14.66
Category Returns
-6.82%
22.09%
3Y Returns
14.66 %
About Kotak Healthcare Fund Direct - IDCW Reinvestment
Kotak Healthcare Fund Direct - IDCW Reinvestment scheme return performance in last 1 year is 8.30%, is 39.21% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
AUM: | ₹453.45 Cr |
Category: | Equity: Sectoral-Pharma |
Launch Date: | Invalid date |
Fund Type: | Open-End |
AMC Information
Kotak Mahindra Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,03,499
₹1,06,749
₹1,06,539
₹1,08,298
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹8,298
8.30%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk